Latest Alpha Tau Medical News & Updates

See the latest news and media coverage for Alpha Tau. We track all announcements, press releases, and industry mentions in real time, all in one place.

Alpha Tau Medical (Alpha Tau)

Developer of alpha radiation therapy for cancer

alphatau.com

Headquarters: Jerusalem , Israel
Founded year: 2016
Company type: Private company
Number of employees: 100–200

Last updated Today

Latest news about Alpha Tau Medical (Alpha Tau)

In short: Alpha Tau completed enrollment for its pivotal U.S. skin cancer trial and reported promising interim data for recurrent glioblastoma treatments.

Company announcements

May 8 Alpha Tau

Alpha Tau reports 100% local control in glioblastoma trial

The first three patients treated showed a 67% complete response rate, with a favorable safety profile.

May 8 Alpha Tau

Alpha Tau completes enrollment in pivotal U.S. trial

Enrollment of all 88 recurrent cSCC patients in the ReSTART pivotal study is complete. Company has initiated a modular PMA submission following FDA Breakthrough Device designation.

May 4 Alpha Tau

Alpha Tau achieves 100% local disease control in pancreatic cancer

The pooled analysis of two trials showed favorable safety, with only 27% of patients experiencing device-related adverse events.

April 23 Alpha Tau

Alpha Tau announces FDA approval to expand pancreatic cancer trial

The expansion allows ten additional patients receiving gemcitabine/nab-paclitaxel and increases total trial size to 40 patients.

Media coverage

May 12 MSN

Alpha Tau Medical (DRTS) price target increased by 13.16% to 10.96

The average one-year price target for Alpha Tau Medical (NasdaqCM:DRTS) has been revised to $10.96 / share. This is an ...

May 12 MSN

Alpha Tau and GE HealthCare mark breakthroughs in radiation therapy

Trial milestone reached: Alpha Tau completed enrolment of 88 patients in its US ReSTART trial for recurrent skin cancer, a key step toward possible FDA...

May 11 MarketWatch

Alpha Tau Medical Shares Gain on Positive Results from Brain-Cancer Treatment Trial

Shares of Alpha Tau Medical climbed after the company disclosed what it called groundbreaking interim results from a trial of its treatment for certain brain...

May 11 Newser

DRTSW (Alpha Tau W) reports quarter with key metrics unavailable as Alpha Tau...

Stay informed with our comprehensive news tools designed for active investors who need timely market information. Alpha Tau W (DRTSW), the warrant associated with Alpha...

Never miss news about Alpha Tau

Track Alpha Tau and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.